Blocking CCR5 activity by maraviroc augmentation in post-stroke depression: a proof-of-concept clinical trial
Abstract Background Post-stroke depression (PSD) is a significant impediment to successful rehabilitation and recovery after a stroke. Current therapeutic options are limited, leaving an unmet demand for specific and effective therapeutic options. Our objective was to investigate the safety of Marav...
Збережено в:
| Автори: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2024-06-01
|
| Серія: | BMC Neurology |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s12883-024-03683-3 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|